2022
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
Haeuser E, Serfes A, Cork M, Yang M, Abbastabar H, Abhilash E, Adabi M, Adebayo O, Adekanmbi V, Adeyinka D, Afzal S, Ahinkorah B, Ahmadi K, Ahmed M, Akalu Y, Akinyemi R, Akunna C, Alahdab F, Alanezi F, Alanzi T, Alene K, Alhassan R, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw E, Amini S, Amugsi D, Ancuceanu R, Anvari D, Appiah S, Arabloo J, Aremu O, Asemahagn M, Jafarabadi M, Awedew A, Quintanilla B, Ayanore M, Aynalem Y, Azari S, Azene Z, Darshan B, Babalola T, Baig A, Banach M, Bärnighausen T, Bell A, Bhagavathula A, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew Z, Bohlouli S, Bolarinwa O, Boloor A, Bozicevic I, Butt Z, Cárdenas R, Carvalho F, Charan J, Chattu V, Chowdhury M, Chu D, Cowden R, Dahlawi S, Damiani G, Darteh E, Darwesh A, das Neves J, Weaver N, De Leo D, De Neve J, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary S, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu I, Ezzikouri S, Farzadfar F, Fattahi N, Fauk N, Fernandes E, Filip I, Fischer F, Foigt N, Foroutan M, Fukumoto T, Gad M, Gaidhane A, Gebregiorgis B, Gebremedhin K, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari M, Gugnani H, Guimarães R, Haider M, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho H, Holla R, Hosseini M, Hosseinzadeh M, Hwang B, Ibitoye S, Ilesanmi O, Ilic I, Ilic M, Islam R, Iwu C, Jakovljevic M, Jha R, Ji J, Johnson K, Joseph N, Joshua V, Joukar F, Jozwiak J, Kalankesh L, Kalhor R, Kamyari N, Kanchan T, Matin B, Karimi S, Kayode G, Karyani A, Keramati M, Khan E, Khan G, Khan M, Khatab K, Khubchandani J, Kim Y, Kisa A, Kisa S, Kopec J, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Defo B, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal D, Landires I, Larson H, Lasrado S, Lee P, Li S, Liu X, Maleki A, Malik P, Mansournia M, Martins-Melo F, Mendoza W, Menezes R, Mengesha E, Meretoja T, Mestrovic T, Mirica A, Moazen B, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Mokdad A, Moradi M, Moraga P, Mubarik S, Mulu G, Mwanri L, Nagarajan A, Naimzada M, Naveed M, Nazari J, Ndejjo R, Negoi I, Ngalesoni F, Nguefack-Tsague G, Ngunjiri J, Nguyen C, Nguyen H, Nnaji C, Noubiap J, Nuñez-Samudio V, Nwatah V, Oancea B, Odukoya O, Olagunju A, Olakunde B, Olusanya B, Olusanya J, Bali A, Onwujekwe O, Orisakwe O, Otstavnov N, Otstavnov S, Owolabi M, Mahesh P, Padubidri J, Pana A, Pandey A, Pandi-Perumal S, Kan F, Patton G, Pawar S, Peprah E, Postma M, Preotescu L, Syed Z, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahmani A, Ramezanzadeh K, Rana J, Ranabhat C, Rao S, Rawaf D, Rawaf S, Rawassizadeh R, Regassa L, Rezaei N, Rezapour A, Riaz M, Ribeiro A, Ross J, Rubagotti E, Rumisha S, Rwegerera G, Moghaddam S, Sagar R, Sahiledengle B, Sahu M, Salem M, Kafil H, Samy A, Sartorius B, Sathian B, Seidu A, Shaheen A, Shaikh M, Shamsizadeh M, Shiferaw W, Shin J, Shrestha R, Singh J, Skryabin V, Skryabina A, Soltani S, Sufiyan M, Tabuchi T, Tadesse E, Taveira N, Tesfay F, Thapar R, Tovani-Palone M, Tsegaye G, Umeokonkwo C, Unnikrishnan B, Villafañe J, Violante F, Vo B, Vu G, Wado Y, Waheed Y, Wamai R, Wang Y, Ward P, Wickramasinghe N, Wilson K, Yaya S, Yip P, Yonemoto N, Yu C, Zastrozhin M, Zhang Y, Zhang Z, Hay S, Dwyer-Lindgren L. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018. BMC Medicine 2022, 20: 488. PMID: 36529768, PMCID: PMC9760541, DOI: 10.1186/s12916-022-02639-z.Peer-Reviewed Original ResearchConceptsHIV prevalenceAge groupsBackgroundHuman immunodeficiency virusJoint United Nations ProgrammeImmune deficiency syndromeHIV prevalence estimatesAdults ages 15HIV/AIDSClinic attendeesUnited Nations ProgrammeImmunodeficiency virusSentinel surveillanceDisease burdenDeficiency syndromePrevalence increasesSeroprevalence surveyPrevalence trendsLow prevalencePrevalence estimatesTreatment interventionsPrevalence differencesTargeted interventionsPrevalenceTreatment effortsAge 15
2021
Longitudinal analysis of client appointment adherence under Universal Test and Treat strategy: A stepped‐wedge trial
Boeke CE, Khan S, Walsh FJ, Lejeune C, Hettema A, Spiegelman D, Okello V, Bärnighausen T. Longitudinal analysis of client appointment adherence under Universal Test and Treat strategy: A stepped‐wedge trial. HIV Medicine 2021, 22: 854-859. PMID: 34293243, DOI: 10.1111/hiv.13144.Peer-Reviewed Original ResearchConceptsImpact of UTTStepped-wedge trialAntiretroviral therapyAppointment adherencePublic sector health systemJoint United Nations ProgrammeMultivariable-adjusted modelsHIV/AIDSUniversal testClient adherenceUTT strategyVisit adherenceHIV clientsUnited Nations ProgrammeStudy enrollmentClinical benefitTreat strategyHealth facilitiesART statusHealth systemAdherenceMarital statusNations ProgrammeMeasures analysisLongitudinal analysis
2018
Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia
Rutledge R, Morozova O, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia. LGBT Health 2018, 5: 484-493. PMID: 30481120, PMCID: PMC6306652, DOI: 10.1089/lgbt.2018.0021.Peer-Reviewed Original ResearchConceptsPrimary care providersRecent HIV testingHIV testingTransgender womenLogistic regressionHIV/AIDS StrategyCorrelates of HIVPrevious depression diagnosisJoint United Nations ProgrammeHIV testing historyBehavioral risk factorsMultivariate logistic regressionYears of ageMental health functioningBivariate logistic regressionUnited Nations ProgrammeHIV statusHIV treatmentRisk factorsHIV epidemicDepression diagnosisAIDS StrategyAmphetamine useCare providersPrevention servicesShifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017
Landis R, Abayomi E, Bain B, Greene E, Janossy G, Joseph P, Kerrigan D, McCoy JP, Nunez C, O'Gorman M, Pastoors A, Parekh B, Quimby K, Quinn TC, Robertson K, Thomas R, van Gorp E, Vermund SH, Wilson V. Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017. AIDS Research And Human Retroviruses 2018, 34: 561-569. PMID: 29732897, PMCID: PMC6053839, DOI: 10.1089/aid.2017.0310.Peer-Reviewed Original ResearchConceptsJoint United Nations ProgrammePublic health benefitsHIV/AIDSPublic health messagingNew medical treatmentsAntiretroviral therapyHIV diseaseUNAIDS 90United Nations ProgrammeMedical treatmentHealth messagingHealth benefitsNations ProgrammeDiseaseInternational expertsCareHealthcare professionsCritical appraisalTreatmentPersistent fearSpirit of optimismStigmaHIVTherapyCommunity level
2017
Adolescents, young people, and the 90–90–90 goals
Wong VJ, Murray KR, Phelps BR, Vermund SH, McCarraher DR. Adolescents, young people, and the 90–90–90 goals. AIDS 2017, 31: s191-s194. PMID: 28665876, PMCID: PMC5497776, DOI: 10.1097/qad.0000000000001539.Peer-Reviewed Original ResearchConceptsHIV testingTreatment initiationJoint United Nations ProgrammeYoung people ages 15People ages 15AIDS 90HIV diagnosisUnited Nations ProgrammePrimary preventionEarly diagnosisHIVNew infectionsAge 15Nations ProgrammeDiagnosisEpidemic controlAdolescentsProgram plannersCurrent low ratesLower ratesYoung peopleNumber of youthRecent studiesTreatmentInitiationEffectiveness of UNAIDS targets and HIV vaccination across 127 countries
Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proceedings Of The National Academy Of Sciences Of The United States Of America 2017, 114: 4017-4022. PMID: 28320938, PMCID: PMC5393239, DOI: 10.1073/pnas.1620788114.Peer-Reviewed Original ResearchConceptsHIV/AIDS 95Joint United Nations ProgrammeOngoing clinical trialsRate of diagnosisBenefits of preventionAntiretroviral therapyHIV vaccinationViral suppressionUNAIDS targetsHIV controlUnited Nations ProgrammeHIV vaccineIncident casesClinical trialsHIV pandemicEnormous morbidityEfficacy vaccineEconomic burdenNew infectionsVaccine developmentDiagnostic approachNations ProgrammeVaccinePreventionTreatment
2016
The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.
Walensky RP, Borre ED, Bekker LG, Resch SC, Hyle EP, Wood R, Weinstein MC, Ciaranello AL, Freedberg KA, Paltiel AD. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa. Annals Of Internal Medicine 2016, 165: 325-33. PMID: 27240120, PMCID: PMC5012932, DOI: 10.7326/m16-0799.Peer-Reviewed Original ResearchConceptsOverall virologic suppressionVirologic suppressionHIV transmissionYears of lifeMaternal orphansTarget strategyHIV/AIDS 90HIV case detectionIncremental cost-effectiveness ratioJoint United Nations ProgrammeHIV transmission ratesSouth African HIVCost of careCost-effectiveness ratioBase-case analysisAIDS 90Incident infectionsAfrican HIVUnited Nations ProgrammeCase detectionHIV detectionTreatment targetsSouth African survey dataRapid treatmentSocietal perspective
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply